Subjects: CUSTOS DOS CUIDADOS DE SAÚDE, ADULTOS, CAMPANHAS DE VACINAÇÃO, PNEUMOPATIAS PARASITÁRIAS (PREVENÇÃO E CONTROLE)
ABNT
SOÁREZ, Patrícia Coelho de et al. Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil. PLOS ONE, v. 10, n. 6, p. 15 , 2015Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0130217. Acesso em: 16 nov. 2024.APA
Soárez, P. C. de, Sartori, A. M. C., Freitas, A. C., Nishikawa, Á. M., & Novaes, H. M. D. (2015). Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil. PLOS ONE, 10( 6), 15 . doi:10.1371/journal.pone.0130217NLM
Soárez PC de, Sartori AMC, Freitas AC, Nishikawa ÁM, Novaes HMD. Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil [Internet]. PLOS ONE. 2015 ; 10( 6): 15 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0130217Vancouver
Soárez PC de, Sartori AMC, Freitas AC, Nishikawa ÁM, Novaes HMD. Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil [Internet]. PLOS ONE. 2015 ; 10( 6): 15 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0130217